Charles Yeo
Overview
Explore the profile of Charles Yeo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
2826
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muller P, Kuemmerli C, Billeter A, Shen B, Jin J, Nickel F, et al.
Ann Surg
. 2024 Nov;
PMID: 39559857
Objective: The aim of this study was to evaluate the different phases of the learning curve for robotic distal pancreatectomy (RDP) in international expert centers. Summary Background Data: RDP is...
2.
Ponzini F, Schultz C, Leiby B, Cannaday S, Yeo T, Posey J, et al.
BMJ Open
. 2023 Oct;
13(10):e073839.
PMID: 37848297
Background: Recent reports of the utilisation of pyrvinium pamoate (PP), an FDA-approved anti-helminth, have shown that it inhibits pancreatic ductal adenocarcinoma (PDAC) cell growth and proliferation in-vitro and in-vivo in...
3.
Muller P, Breuer E, Nickel F, Zani Jr S, Kauffmann E, De Franco L, et al.
Ann Surg
. 2022 Jul;
278(2):253-259.
PMID: 35861061
Background And Objective: Robotic distal pancreatectomy (DP) is an emerging attractive approach, but its role compared with laparoscopic or open surgery remains unclear. Benchmark values are novel and objective tools...
4.
Deng A, Wang C, Cohen S, Winter J, Posey J, Yeo C, et al.
Eur J Cancer
. 2021 Feb;
147:17-28.
PMID: 33607382
Purpose: To compare overall survival (OS) in patients who underwent surgery for early-stage pancreatic adenocarcinoma (rPca) based on sequence (NAT, neoadjuvant therapy and/or AT, adjuvant therapy) and type (SA, single-agent...
5.
Londin E, Loher P, Telonis A, Quann K, Clark P, Jing Y, et al.
Proc Natl Acad Sci U S A
. 2015 Feb;
112(10):E1106-15.
PMID: 25713380
Two decades after the discovery of the first animal microRNA (miRNA), the number of miRNAs in animal genomes remains a vexing question. Here, we report findings from analyzing 1,323 short...
6.
Shen J, Weinstein M, Beekley A, Yeo C, Cowan S
Am Surg
. 2014 Jun;
80(6):536-8.
PMID: 24887788
In their extensive writings, Hippocrates and Celsus counseled physicians to be knowledgeable in both the medical and surgical management of patient recovery. However, their words fell by the wayside because...
7.
8.
Herman J, Swartz M, Hsu C, Winter J, Pawlik T, Sugar E, et al.
J Clin Oncol
. 2008 Jul;
26(21):3503-10.
PMID: 18640931
Purpose: To examine the efficacy of adjuvant chemoradiotherapy after pancreaticoduodenectomy (PD) for pancreatic adenocarcinoma (PC) in patients undergoing resection at Johns Hopkins Hospital (JHH; Baltimore, MD). Patients And Methods: Between...
9.
Infante J, Matsubayashi H, Sato N, Tonascia J, Klein A, Riall T, et al.
J Clin Oncol
. 2007 Jan;
25(3):319-25.
PMID: 17235047
Purpose: SPARC (secreted protein acidic and rich in cysteine) is a protein involved in cell matrix interactions, wound repair, and cell migration, and has been reported to inhibit cancer growth....
10.
Rubio-Viqueira B, Jimeno A, Cusatis G, Zhang X, Iacobuzio-Donahue C, Karikari C, et al.
Clin Cancer Res
. 2006 Aug;
12(15):4652-61.
PMID: 16899615
Effective development of targeted anticancer agents includes the definition of the optimal biological dose and biomarkers of drug activity. Currently available preclinical models are not optimal to this end. We...